Tilray Brands Inc TLRY shares are trading lower Thursday after the company reported earnings results that were down year-over-year.
Tilray said fiscal fourth-quarter revenue increased 8% year-over-year to $153.3 million. Full fiscal year 2022 revenue jumped 22% year-over-year to $628 million.
Tilray reported a quarterly earnings loss of 90 cents per share, which was down from earnings of 38 cents per share year-over-year.
"Over the past year, we have accelerated the optimization of our operations and sharpened execution against our most profitable core business opportunities in medical, adult-use, wellness, and beverage-alcohol across Canada, Europe, and the U.S.," said Irwin Simon, chairman and CEO of Tilray.
Tilray said it expects to generate between $70 million and $80 million of adjusted EBITDA in fiscal year 2023. The company also expects to be free cash flow positive in its operating business units in 2023.
Tilray is a global cannabis-lifestyle and consumer packaged goods company.
See Also: Video: The Most Discrete Way To Consume Cannabis? This Dosing Device Will Blow Your Mind
TLRY Price Action: Tilray has traded between $9.08 and $3 over a 52-week period.
The stock was down 1.53% at $3.21 at press time, according to data from Benzinga Pro.
Photo: NickyPe from Pixabay.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.